;
Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Eleven raises $20M in private placement

    Eleven Biotherapeutics Inc. (NASDAQ:EBIO) raised $20 million through the sale of 1.7 million shares at $11.47 in a private placement with undisclosed investors. The company also issued three-year warrants to purchase …

    Published on 11/25/2014
  • FINANCIAL NEWS: Medgenics raises $21M in follow-on

    Medgenics Inc. (NYSE-M:MDGN) raised $21 million through the sale of 5.1 million shares at $4.10 in a follow-on underwritten by Piper Jaffray and JMP Securities.Medgenics' lead compound, TARGTEPO (MDGN-201), is in Phase …

    Published on 11/25/2014
  • FINANCIAL NEWS: Promethera raises EUR 20.3M in series C

    Liver disease company Promethera Biosciences S.A. (Mont-Saint-Guibert, Belgium) raised EUR 20.3 million ($25.2 million) in a series C round led by existing investor Vesalius BioCapital. New investors included Germany's …

    Published on 11/25/2014
  • FINANCIAL NEWS: Ampio's Vyrix withdraws IPO

    The Vyrix Pharmaceutical Inc. subsidiary of Ampio Pharmaceuticals Inc. (NYSE-M:AMPE) withdrew its proposed IPO on NYSE MKT, citing market conditions. In April, Vyrix filed to raise up to $28.8 million. Aegis Capital and…

    Published on 11/24/2014
  • FINANCIAL NEWS: Invus adds $150M to Lexicon investment

    Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) raised $150 million from an affiliate of Invus by selling shares in a private placement at $1.005 per share. The deal was disclosed in an SEC filing that also described the …

    Published on 11/24/2014
  • FINANCIAL NEWS: OnCore moving fast toward IPO

    In the wake of two deals to acquire HBV assets, OnCore Biopharma Inc. (Doylestown, Pa.) on Monday said it had submitted draft registration materials to SEC for a proposed IPO.OnCore was founded in 2012 by former …

    Published on 11/24/2014
  • FINANCIAL NEWS: Polaris closes Fund VII with $450M

    Polaris Partners closed its oversubscribed seventh fund with $450 million, with about half to be invested in healthcare and the balance in technology. The firm typically invests $10-$20 million per company and plans to …

    Published on 11/24/2014
  • FINANCIAL NEWS: Sinopharm to raise $727.8M

    The Sinopharm Group Co. Ltd. (Hong Kong:01099) subsidiary of China National Pharmaceutical Group Corp. (Sinopharm) said it will raise HK$5.6 billion ($727.8 million) through the sale of 198.8 million shares at HK$28.40 …

    Published on 11/24/2014
  • FINANCIAL NEWS: Banker tracks

    Dresner Partners hired Robert Friedman as managing director, healthcare. Friedman was most recently managing director at Northeast Securities, and previously co-head of healthcare investment banking for Burnham …

    Published on 11/21/2014
  • FINANCIAL NEWS: Lexicon raises $130M in follow-on and notes

    Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) raised $80 million through the sale of senior convertible notes and $50 million in a follow-on through the sale of 49.8 million shares at $1. JP Morgan; Goldman Sachs; Needham;…

    Published on 11/21/2014
  • FINANCIAL NEWS: BioNano raises $53M in series C

    BioNano Genomics Inc. (San Diego, Calif.) raised $53 million in an untranched series C round led by new investors Legend Capital and Novartis Venture Fund. Other new investors included Federated Kaufmann Fund and …

    Published on 11/20/2014
  • FINANCIAL NEWS: Celsus planning $46M follow-on

    Inflammation and dermatology play Celsus Therapeutics plc (NASDAQ:CLTX) intends to raise up to $46 million in a follow-on underwritten by Cowen; Piper Jaffray; and MTS. The offering will comprise American Depositary …

    Published on 11/20/2014
  • FINANCIAL NEWS: EyeGate downsizes proposed IPO

    Ophthalmology company EyeGate Pharmaceuticals Inc. (Waltham, Mass.) amended terms for its proposed IPO on NASDAQ underwritten by Aegis Capital Corp. The company now plans to sell 1.4 million shares at $6-$8. At $7, …

    Published on 11/20/2014
  • FINANCIAL NEWS: Neothetics loses ground after $65.1M IPO

    Neothetics Inc. (NASDAQ:NEOT) fell $2 (14%) to $12 in its first day of trading on Thursday after it raised $65.1 million through the sale of 4.7 million shares at $14 in an IPO. The deal valued Neothetics at $190.7 …

    Published on 11/20/2014
  • FINANCIAL NEWS: Rockwell dips after $58.5M follow-on

    Rockwell Medical Inc. (NASDAQ:RMTI) lost $0.90 to $8.91 on Thursday after it raised $58.5 million through the sale of 6.5 million shares at $9 in a follow-on underwritten by BofA Merrill Lynch; Stifel; Summer Street; …

    Published on 11/20/2014
  • FINANCIAL NEWS: Trevena planning $40M follow-on

    Neurology company Trevena Inc. (NASDAQ:TRVN) proposed to raise $40 million in a follow-on underwritten by Barclays; Cowen; Jefferies; JMP; and Needham.Trevena is developing GPCR ligands that activate or block specific …

    Published on 11/20/2014
  • FINANCIAL NEWS: Amicus raises $90 million on back of Amigal

    Amicus Therapeutics Inc. (NASDAQ:FOLD) raised $90 million to commercialize its Amigal migalastat to treat Fabry's disease after pricing a follow-on of 13.9 million shares at $6.50 per share on Wednesday. Amicus intends …

    Published on 11/19/2014
  • FINANCIAL NEWS: Baird closes oversubscribed Fund IV at $185M

    Baird Capital closed its fourth venture fund, BVP IV, at $185 million, exceeding its target of $150 million. The firm invests in technology and healthcare companies, with an emphasis on medical devices and diagnostics.…

    Published on 11/19/2014
  • FINANCIAL NEWS: N30 raises $30 million

    N30 Pharmaceuticals Inc. (Boulder, Colo.) raised $30 million in a mezzanine financing. New investors included Wellington; RA Capital; Jennison; Rock Springs; and Sabby. Existing investor Deerfield also participated. …

    Published on 11/19/2014
  • FINANCIAL NEWS: Receptos rises after $360M offering

    Receptos Inc. (NASDAQ:RCPT) gained $4.97 to $107.95 Wednesday after it raised $360 million through the sale of 3.6 million shares at $100 in a follow-on underwritten by Credit Suisse; Leerink; Evercore; BMO; Wedbush …

    Published on 11/19/2014
  • FINANCIAL NEWS: Bellicum files for IPO

    Bellicum Pharmaceuticals Inc. (Houston, Texas) filed to raise up to $115 million in an IPO on NASDAQ underwritten by Jefferies; Citigroup; and Piper Jaffray. The company is conducting multiple Phase I/II trials of BPX-…

    Published on 11/18/2014
  • FINANCIAL NEWS: Juno IPO promises academic paydays

    Cancer immunotherapy developer Juno Therapeutics Inc. (Seattle, Wash.) will be obligated to pay two of its academic collaborators up to $525 million if its stock price exceeds certain thresholds within 11 years of its …

    Published on 11/18/2014
  • FINANCIAL NEWS: Onxeo proposes EUR 35.4M rights offering

    Orphan cancer company Onxeo S.A. (Euronext:ONXEO) proposed to raise EUR 35.4 million ($44.1 million) in a rights offering underwritten by Natixis and Oddo & Cie. The company plans to issue 7.9 million shares at EUR 4.50…

    Published on 11/18/2014
  • FINANCIAL NEWS: Amicus planning $75M follow-on

    Amicus Therapeutics Inc. (NASDAQ:FOLD) said it plans to raise $75 million in a follow-on underwritten by JPMorgan; Cowen; Leerink; and Janney Montgomery Scott. The company is planning to commercialize globally its …

    Published on 11/17/2014
  • FINANCIAL NEWS: Receptos proposes $325M follow-on

    Receptos Inc. (NASDAQ:RCPT) said it plans to raise $325 million in a follow-on underwritten by Credit Suisse; Leerink; Evercore; BMO; Wedbush; and Nomura. In two prior follow-ons this year, Receptos raised $117.4 …

    Published on 11/17/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993